Skip to main content

Peer Review reports

From: A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

Original Submission
8 Nov 2011 Submitted Original manuscript
10 Nov 2011 Author responded Author comments - Björn Stollenwerk
Resubmission - Version 2
10 Nov 2011 Submitted Manuscript version 2
26 Mar 2012 Reviewed Reviewer Report - carlo lucioni
29 Mar 2012 Reviewed Reviewer Report - Sue Jowett
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
18 May 2012 Author responded Author comments - Björn Stollenwerk
30 May 2012 Reviewed Reviewer Report - Sue Jowett
Resubmission - Version 6
18 May 2012 Submitted Manuscript version 6
Publishing
11 Jun 2012 Editorially accepted
9 Jul 2012 Article published 10.1186/1472-6963-12-192

You can find further information about peer review here.

Back to article page